Targeting chemotherapy-induced PTX3 in tumor stroma to prevent the progression of drug-resistant cancers.
about
PTX3, a humoral pattern recognition molecule at the interface between microbe and matrix recognition.The Dual Complexity of PTX3 in Health and Disease: A Balancing Act?Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis.MCM10 overexpression implicates adverse prognosis in urothelial carcinoma.PLCB4 copy gain and PLCß4 overexpression in primary gastrointestinal stromal tumors: Integrative characterization of a lipid-catabolizing enzyme associated with worse disease-free survival.Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma.Lysosomal acid phosphatase 2 is an unfavorable prognostic factor but is associated with better survival in stage II colorectal cancer patients receiving chemotherapy.Sulfatase-1 overexpression indicates poor prognosis in urothelial carcinoma of the urinary bladder and upper tractOleate-induced PTX3 promotes head and neck squamous cell carcinoma metastasis through the up-regulation of vimentin.Pentraxin-3 is a PI3K signaling target that promotes stem cell-like traits in basal-like breast cancers.Bortezomib-induced miRNAs direct epigenetic silencing of locus genes and trigger apoptosis in leukemia.PTX3, a Humoral Pattern Recognition Molecule, in Innate Immunity, Tissue Repair, and Cancer.Tumor-induced Stromal STAT1 Accelerates Breast Cancer via Deregulating Tissue Homeostasis.C-reactive protein and hepatocellular carcinoma: analysis of its relationships to tumor factors.
P2860
Q33632044-13C426D0-0503-4656-96A4-8D897C268331Q33632047-8FC3F050-6443-4B0F-A608-7B534203E369Q36122605-38C2CDED-DCD2-4AA8-AA26-FE68CB7FFA95Q37718437-B04C3DC7-C978-4CAF-A9F7-AB04D44A5588Q37746218-311300B3-D329-4F54-8D91-2D15CD0B05E1Q38720813-92AC7814-4B2D-4233-8BFB-366FEF8F112CQ38721905-6B12445C-9C4E-4C87-A691-38D19B9881FDQ38774630-AED97273-4B0B-403E-8874-E093BBF2481CQ41093646-F32C9648-BD4F-41BB-B4E8-CBA0CBA200C3Q42505998-27EB8A10-9075-4FE4-95A9-327601E78C5EQ47421833-79ADE7DB-A554-4D6F-AF3F-658B7A97F98DQ50143105-9092C835-A91F-49FD-8EA7-5B7379FE5B19Q54764898-7F5EEB4A-A84B-4D6E-B0E1-356E5E0AD751Q55322477-96ACA31F-BCD6-4F0D-A853-21DB7A355A01
P2860
Targeting chemotherapy-induced PTX3 in tumor stroma to prevent the progression of drug-resistant cancers.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Targeting chemotherapy-induced ...... ion of drug-resistant cancers.
@ast
Targeting chemotherapy-induced ...... ion of drug-resistant cancers.
@en
type
label
Targeting chemotherapy-induced ...... ion of drug-resistant cancers.
@ast
Targeting chemotherapy-induced ...... ion of drug-resistant cancers.
@en
prefLabel
Targeting chemotherapy-induced ...... ion of drug-resistant cancers.
@ast
Targeting chemotherapy-induced ...... ion of drug-resistant cancers.
@en
P2093
P2860
P356
P1433
P1476
Targeting chemotherapy-induced ...... ion of drug-resistant cancers.
@en
P2093
Ben-Kuen Chen
Chien-Feng Li
Jhen-Yi Hong
Jhih-Ying Chi
Ju-Ming Wang
Kelvin K Tsai
Shao-Ming Wang
Yang-Ming Liu
Yu-Chih Lo
P2860
P304
23987-24001
P356
10.18632/ONCOTARGET.4364
P407
P577
2015-06-08T00:00:00Z